Rx-to-OTC Switch Movement

American Druggist. "What 1,458 RPH's Think of Rx-to-OTC Trend." American Druggist 189, no. 1 (1984): 12-29.

Angier, N. "Future of the Pill May Lie Just over the Counter." New York Times, 8 August 1993: E5.

Beard, K. "Adverse Reactions as a Cause of Hospital Admissions in the Aged." Drugs and Aging 2, no. 4 (1992): 356-67.

Beauchamp, T. "The Promise of the Beneficence Model for Medical Ethics." Journal of Contemporary Health Law and Policy 127, no. 6 (1990): 145-55.

Bectel, M. "The Rx-OTC Switch: Good for Pharmacy." American Pharmacy (April 1984): 184-87.

Belkin, L. "Doctors Lose Autonomy to Health Care Networks." New York Times, 12 November 1991: A1,B12.

Bernstein, M. Regulating Business by Independent Commission. Princeton, NJ: Princeton University Press, 1955.

Berridge, V. , and G. Edwards. Opium and the People; Opiate Use in Nineteenth-Century England. London: Allen Lane, St. Martin's Press, 1981.

Blishen, B. Doctors in Canada: The Changing World of Medical Practice. Toronto: University of Toronto Press, 1991.

Bruch, M.K. , and E. Larson. "An Early Historical Perspective on the FDA's Regulation of OTC Drugs." Infection Control and Hospital Epidemiology 10, no. 11 (1989): 527-28.

Brushwood, D.B. Medical Malpractice, Pharmacy Law. Colorado Springs, CO : McGraw-Hill Book Co., 1986 .

Chan, K-C. "Nonprescription Drugs: Over the Counter and Underemphasized." GAOT-PEMD-(2-5). Gaithersburg, MD: GAO, 1992.

Chassin, M., et al. "How Coronary Angiography Is Used: Clinical Determinants of Appropriateness." Journal of the American Medical Association 258, no. 18 (13 November 1987): 2543-47.

Christensen, D.B. , W.E. Fassett , and G.A. Andrews. "A Practical Billing and Payment Plan for Cognitive Services ." American Pharmacy (New Series) 33, No. 3 (March 1993): 34-40.

Consumer Reports. "Pushing Drugs to Doctors." Consumer Reports 57, no. 2 (February 1992a): 87-95.

—. " Miracle Drugs or Media Drugs?" Consumer Reports 57, no. 3 (March 1992b): 142-46.

Cope, J.D. "You Can Do Something About the Weather; 12 Suggestions on How to Change the Climate." Speech delivered to the 10th General Assembly of the World Federation of Proprietary Medicine Manufacturers , Seoul Korea, 18 October 1991, 1-14.

Cosminsky, S. , and M. Scrimshaw. "Medical Pluralism on a Guatemalan Plantation." Social Science and Medicine 1413 ( 1980): 267-78.

Duncan, W. , and M. Weber. Profits, Politics and Drugs. New York : Holmes and Meir, Publishers, 1979.

Eckholm, E. "Budget Cutters Discover Easy Target in Medicare." New York Times, 10 August 1993: A14.

Farley, D. "Benefit vs. Risk: How FDA Approves New Drugs." FDA Consumer (December 1987-January 1988): 7-18.

FDA Consumer. "Agency Reviews Comments on OTC Ingredient Ban." FDA Consumer 24, no. 7 (September 1990): 5.

FDA/PA Symposium. Self-Care Self-Medication in America's Future: Report of a Symposium. Washington DC: Food and Drug Administration and Proprietary Association, February 1988.

Feder, B. "It's Not Just Breast Implants the F.D.A. Is After." New York Times, 29 March 1992: E1.

Feldman, R. , H-C. Chan , J. Kralewski , B. Dowd , and J. Shapiro. "Effects of HMOs on the Creation of Competitive Markets for Hospital Services." Journal of Health Economics 9 (1990): 207-22.

Ferguson, T. "Patient, Heal Thyself; Health in the Information Age." The Futurist 26, no. 1 (January-February 1992): 9-13.

Fisher, G.M. "Legal Aspects of Rx/OTC Switches." Paper presented at the Regulatory Affairs Professionals Society Annual Meeting , September 16, 1987. NDMA Reprints, Washington, DC, 1-5.

Fletcher, F.M. Market Restraint in the Retail Drug Industry. Philadelphia : University of Pennsylvania Press, 1967.

Freidson, E. "The Reorganization of the Medical Profession." Medical Care Review 42, no. 1 (Spring 1985): 11-36.

Freudenheim, M. "Though Markets Vary, Drugs Work Anywhere." New York Times 1 January 1992a: A21.

—. "Software Controls on Health Costs." New York Times 8 February 1992b: C2.

—. "Keeping the Pipeline Filled at Merck." New York Times 16 February 1992c: Section 3, pp. 1, 6.

Gans, J. , and G. Hogan. Transitional Class of Drugs: Policy Actions. Bethesda, MD: American Society of Hospital Pharmacists, House of Delegates, 1985.

Gilbert, P. , L. Sikes , L. Lipsen , and K. Marder. "The FDA Excuse." Washington, DC: Public Citizen's Congress Watch, U.S. Public Interest Research Group, Consumers Union and Consumer Federation of America, 1990.

Gopal, K. "A British Perspective on the OTC Market." Pharmaceutical Executive (May 1991): 42-56.

Grabowski, H. , and J. Vernon. The Regulation of Pharmaceuticals. Washington, DC: American Enterprise Institute, 1983.

Grimes, D.A. "Editorial: Over-the-Counter Oral Contraceptives—An Immodest Proposal?" American Journal of Public Health 83 (1993): 1092-93.

Haas, E. "Tighten the Rules on Seafood Safety." New York Times , 27 February 1992: A19.

Hadeler, F. "Warning: OTCs (Over the Counter Medications) May Be Hazardous to Your Health." Unpublished paper, 1985.

Hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-Eighth Congress. First Session on the Food and Drug Administration's Policies and Procedures in Switching Drugs from Prescription to Over-the-Counter Status. Washington, DC: Government Printing Office, 1983.

Hilts, P. "Proposal Seeks to Speed Up Federal Approval of Drugs." New York Times 9 November 1991: 7.

—. "F.D.A. and Quayle Council Sparred on Drug Approvals" New York Times (March 20 1992): A34.

Juhl, R.P. "The Nonprescription Drug Advisory Committee and the Rx-to-OTC Process ." Paper presented at the Spring Forum, Tufts Center for the Study of Drug Development, Tufts University , Boston, MA, May 24, 1994.

Kaplan, A. "OTC and Prescription Drugs: The Legal Distinction under Federal Law ." In Rx OTC New Resources in Self-Medication, A Symposium . Washington, DC: Proprietary Association , 1982.

Kolata, G. "Questions Raised on Ability of F.D.A. to Protect Public." New York Times 26 January 1992: 1, 16.

Lambert, E.C. Modern Medical Mistakes. Bloomington: Indiana University Press, 1978.

Lamy, P.P. "Drug Abuse by Older Adults—Who is Responsible?" Drug Intelligence and Clinical Pharmacy 17 (September 1983): 657-59.

Leary, W. "Report Says F.D.A. Is Law on Over-the-Counter Drugs." New York Times, 27 February 1992a: A8.

—. "U.S. Urges Doctors to Fight Surgical Pain (and Myths." New York Times, 6 March 1992b: A1 A9,

—. "Additional Advice for Physicians: Update Guidelines on Treatments ." New York Times, 15 April 1992c: B8.

Luce, B. "Medical Technology and Its Assessment." In Introduction to Health Services, edited by S. Williams and P. Torrens. New York: John Wiley & Sons, 1988.

Madhavan, S. "Factors Influencing Pharmacists' Preference for Pharmacist-Legend Status and Other Conditions of Sale for Rx-to-OTC Switched Drug Products." Journal of Clinical Pharmacy Therapeutics (June 1993 ):

Madhavan, S. , and P. Gore. "A Multidimensional Analysis of Physicians' Perceptions of Rx-to-OTC Switched Drug Products." Journal of Pharmaceutical Marketing and Management, forthcoming, Fall 1994.

Madhavan, S. , and S.W. Schondelmeyer . "Factors Influencing Pharmacists' Preference for the Legal Classification of Rx-To-OTC Switched Drug Products." Journal of Clinical Pharmacy and Therapeutics (June 1993): 281-90.

McKinley, J.B. , and J. Arches. "Towards the Proletarianization of Physicians." International Journal of Health Services 15, no. 2 (1985): 161-195.

McKinley, J.B. , and J.D. Stoechle. "Corporatization and the Social Transformation of Doctoring ." International Journal of Health Services 18, no. 2 (1988): 191-205.

Meier, K.J. Regulation: Politics, Bureaucracy, and Economics. New York : St. Martin's Press, 1985.

Merck and Company. "Health Care Innovation: The Case for a Favorable Public Policy." No place of publication, n.d.

Morse, M.L. "Therapeutic Drug Use Review Reduces Incidence of Drug Related Illness . Business and Health 3, no. 3 (January-February 1986): 58-59.

Nadakavukaren, A. Man & Environment. Prospect Heights, IL: Waveland Press, 1990.

Nadel, M. The Politics of Consumer Protection. Indianapolis: IN: Bobbs-Merrill, 1971.

Nonprescription Drug Manufacturers Association. " NDMA Fact Sheet on Rx-to-OTC Switch." Washington, DC: NDMA, 1991.

Paulus, H. "FDA Arthritis Advisory Committee Meeting: Guidelines for Approving Nonsteroidal Antiinflammatory Drugs for Over-the-Counter Use." Arthritis and Rheumatism 33, no. 7 (1990): 1056-58.

Pear, R. "Drug Industry Gathers a Mix of Voices to Bolster Its Case." New York Times, 7 July 1993: A1 A12,

Proprietary Association. Rx OTC New Resources in Self-Medication, a Symposium. Washington D.C.: The Proprietary Association, 1982.

—. Health Care Practices and Perceptions. Washington, DC: Office of Public Affairs, Proprietary Association , 1984 .

—. Self-Care Self-Medication in America's Future, Report of a Symposium: Condensation of Papers and Discussions. Washington, DC : Proprietary Association, 1988 .

Quirk, P. "Food and Drug Administration." In The Politics of Regulation , edited by J. Q. Wilson. New York: Basic Books, 1980.

Rachanow, G. "The Switch of Drugs from Prescription to Over-the-Counter Status." Food, Drug, Cosmetic Law Journal 39 ( 1984): 201-10.

Reagan, M.D. Regulation: The Politics of Policy. Boston: Little, Brown, and Company, 1987.

Rheinstein, P.H. "Criteria Used by the FDA to Determine What Classes of Drugs Are Appropriate Switch Candidates." Drug Information Journal 19 (1985): 139-42.

Rice, T. "Containing Health Care Costs in the United States." Medical Care Review 49, no. 1 (1992): 19-65.

Roper, W. , W. Winkenwerder , G. Hackbarth , and H. Krakauer. "Effectiveness in Health Care." The New England Journal of Medicine 319, no. 18 (3 November 1988): 1197-1202.

Rosen, A. "OTC Formula for Success." Medical Advertising News (August 1991).

Rosenau, P. Post-Modernism and the Social Sciences. Princeton, NJ: Princeton University Press, 1992.

Rosenau, P. , and C. Thoer. "Liberalizing Access to Medications." In Contested Ground: Public Purposes and Private Interest in the Regulation of Prescription Drugs, edited by P. Davis. New York: Oxford University Press, forthcoming 1995.

Rosenthal, E. "As Costs of New Drugs Rise, Hospitals Stick by Old Ones." New York Times, 18 December 1991: A1 B11,

Segal, A. "A Community Survey of Self-Medication." Medical Care 28, no. 4 (1990): 301-10.

Segal, M. "Rx-to-OTC: The Switch Is On." FDA Consumer 25, no. 2 (March 1991 ): 8-11.

Silverman, H.I. "What Lies Ahead for Rx-to-OTC Switches." Drug and Cosmetic Industry (August 1987): NDMA Reprint, Washington, DC, 1-4.

Silverman, M. , and P.R. Lee. Pills, Profits, and Politics. Berkeley and Los Angeles : University of California Press, 1974.

Statman, M. Competition in the Pharmaceutical Industry: The Declining Profitability of Drug Innovations. Washington, DC: American Enterprise Institute, 1983.

Temin, P. "Technology, Regulations and Market Structure in the Modern Pharmaceutical Industry." Bell Journal of Economics 10, no. 2 (1979a): 429-43.

—. "Origins of Compulsory Drug Prescriptions." Journal of Law and Economics 22, no. 1 (1979b): 91-105.

—. "Regulation and the Choice of Prescription Drugs." American Economics Review 70, no. 2 (1980a): 301-305.

—. Taking Your Medicine: Drug Regulation in the United States. Cambridge, MA: Harvard University Press , 1980b.

—. "Costs and Benefits in Switching Drugs from Rx-to-OTC." pp. 15-21 in Rx OTC: New Resources in Self-Medication, a Symposium. Washington, DC: Proprietary Association, 1982 . The full text of this article is published under the same title in Journal of Health Economics 2 (1983): 187-205.

—. "Government Actions in Times of Crisis: Lessons from the History of Drug Regulation." Journal of Social History 18, no. 3 (1985): 433-38.

—. "Realized Benefits from Switching Drugs." Washington, DC: Nonprescription Drug Manufacturers Association , 1990.

Teplitsky, B. "How to Help the Elderly to Comply with Their Drug Therapy." Pharmacy Times 51, no. 1 (January 1985): 104-106.

Thompson, F. , and L.R. Jones. Regulatory Policy and Practices: Regulating Better and Regulating Less. Westport, CT: (Praeger) Greenwood, 1982.

Trussell, J. , F. Stewart , M. Potts , F. Guest , and C. Ellertson. "Should Oral Contraceptives Be Available without Prescription? " American Journal of Public Health 83, no. 8 (1993): 1094-99.

Veverka, M.J. "The Emerging Program to Achieve User Fee Goals." Food and Drug Law Journal 48, no. 1 (1993): 11-15.

Wardell, W. , and L. Lasagna. Regulation and Drug Development. Washington, DC: American Enterprise Institute for Public Policy Research, 1975.

Welch, W.P. , A.L. Hillman , and M.V. Pauly. "Toward New Typologies for HMOs." Milbank Quarterly 68, no. 2 (1990): 221-41.

Wenders, J.T. "Deregulating Telecommunications." In Regulation and the Reagan Era: Politics, Bureaucracy and the Public Interest, edited by R. Meiners and B. Yandle. New York: Holmes and Meier, 1989.

Wennberg, J.E. "Outcomes Research, Cost Containment, and the Fear of Health Care Rationing." The New England Journal of Medicine 323, no. 17 (25 October 1990): 1202-1204.

Wenneker, M. , J. Weissman , and A. Epstein. "The Association of Payer with Utilization of Cardiac Procedures in Massachusetts." Journal of the American Medical Association 264, no. 10 (12 September 1990): 1255-60.

Widgery, D. "Postmodern Medicine." British Medical Journal 298, no. 6677 (1 April 1989): 897.

Wiener, J. "Hitting the FDA ... Again." Medicine and Health Perspectives 44, no. 41 (22 October 1990): 1-4.

Wilcox, S.M. , D.U. Himmelstein , and S. Woolhandler. "Inappropriate Drug Prescribing for the Community-Dwelling Elderly." Journal of the American Medical Association 272, no. 4 (27 July 1994): 292-96.

Winters, P. , and L. Freeman. "New OTC Drugs to Flood Market." Advertising Age 61, no. 28 (9 July 1990): 3, 41.

Wion, A.H. "Rx—to—OTC—The Process and Procedures." Drug Information Journal 19 (1985 ): 119-26.

World Federation of Proprietary Medicine Manufacturers. Health Care, Self-Care and Self-Medication. London , England: WFPMM, n.d.

Young, F.E. "A Theme in Three Parts: Science; Society; the Economy." In Self-Care Self-Medication in America's Future: Report of a Symposium . Washington, DC: Proprietary Association, 1988.